Mimedx Group Stock Performance
| MDXG Stock | USD 9.12 0.04 0.44% |
On a scale of 0 to 100, MiMedx holds a performance score of 15. The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MiMedx's returns are expected to increase less than the market. However, during the bear market, the loss of holding MiMedx is expected to be smaller as well. Please check MiMedx's maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to make a quick decision on whether MiMedx's current price movements will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MiMedx Group are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, MiMedx reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.28) | Five Day Return 4.2 | Year To Date Return (2.42) | Ten Year Return 7.16 | All Time Return 95.15 |
Last Split Date 2008-04-02 |
1 | Can MiMedx Climb 77.92 percent to Reach the Level Wall Street Analysts Expect | 11/04/2024 |
2 | How Much Upside is Left in MiMedx Wall Street Analysts Think 37.12 | 11/20/2024 |
3 | Global 35 Bn Wound Care Market Forecasts to 2032 Increased Adoption of Smart Dressings, Bioengineered Tissues, and Digital Wound Monitoring Fueling Developments... | 11/25/2024 |
4 | Recent Price Trend in MiMedx is Your Friend, Heres Why | 12/02/2024 |
5 | Point72 Asia Singapore Pte. Ltd. Has 122,000 Stock Holdings in MiMedx Group, Inc. | 12/06/2024 |
6 | Acquisition by Maersk-moller Kimberly of 125581 shares of MiMedx subject to Rule 16b-3 | 12/11/2024 |
7 | MIMEDX Groups SWOT analysis wound care firms stock faces growth hurdles | 12/12/2024 |
8 | MIMEDX Files Patent Infringement Lawsuit Against Surgenex | 12/17/2024 |
9 | MIMEDX Groups SWOT analysis wound care firms stock faces market headwinds | 12/18/2024 |
10 | MiMedx Group, Inc.s Stocks On An Uptrend Are Strong Financials Guiding The Market | 01/07/2025 |
11 | MiMedx Group Updates Investor Presentation in Recent 8-K Filing | 01/16/2025 |
| Begin Period Cash Flow | 66 M |
MiMedx |
MiMedx Relative Risk vs. Return Landscape
If you would invest 570.00 in MiMedx Group on October 20, 2024 and sell it today you would earn a total of 342.00 from holding MiMedx Group or generate 60.0% return on investment over 90 days. MiMedx Group is currently generating 0.8563% in daily expected returns and assumes 4.3306% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than MiMedx, and 83% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MiMedx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MiMedx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MiMedx Group, and traders can use it to determine the average amount a MiMedx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1977
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MDXG | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.86 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average MiMedx is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MiMedx by adding it to a well-diversified portfolio.
MiMedx Fundamentals Growth
MiMedx Stock prices reflect investors' perceptions of the future prospects and financial health of MiMedx, and MiMedx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MiMedx Stock performance.
| Return On Equity | 0.62 | ||||
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.26 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 1.26 B | ||||
| Shares Outstanding | 146.95 M | ||||
| Price To Earning | 23.73 X | ||||
| Price To Book | 7.16 X | ||||
| Price To Sales | 3.78 X | ||||
| Revenue | 321.48 M | ||||
| Gross Profit | 285.8 M | ||||
| EBITDA | 40.52 M | ||||
| Net Income | 67.44 M | ||||
| Cash And Equivalents | 72.5 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 48.1 M | ||||
| Debt To Equity | 0.69 % | ||||
| Current Ratio | 3.53 X | ||||
| Book Value Per Share | 1.23 X | ||||
| Cash Flow From Operations | 26.77 M | ||||
| Earnings Per Share | 0.57 X | ||||
| Market Capitalization | 1.33 B | ||||
| Total Asset | 239.05 M | ||||
| Retained Earnings | (133.68 M) | ||||
| Working Capital | 118.25 M | ||||
| Current Asset | 96.31 M | ||||
| Current Liabilities | 26.78 M | ||||
About MiMedx Performance
By analyzing MiMedx's fundamental ratios, stakeholders can gain valuable insights into MiMedx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MiMedx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MiMedx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 161.50 | 135.29 | |
| Return On Tangible Assets | 0.28 | 0.30 | |
| Return On Capital Employed | 0.17 | 0.18 | |
| Return On Assets | 0.25 | 0.27 | |
| Return On Equity | 0.43 | 0.40 |
Things to note about MiMedx Group performance evaluation
Checking the ongoing alerts about MiMedx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MiMedx Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MiMedx Group appears to be risky and price may revert if volatility continues | |
| MiMedx Group is unlikely to experience financial distress in the next 2 years | |
| About 68.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: MiMedx Group Updates Investor Presentation in Recent 8-K Filing |
- Analyzing MiMedx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MiMedx's stock is overvalued or undervalued compared to its peers.
- Examining MiMedx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MiMedx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MiMedx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MiMedx's stock. These opinions can provide insight into MiMedx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |